EXOZ
EXOZYMES INC.Company Information
- Company Name
- EXOZYMES INC.
- CIK
- CIK0002010788
- Category
- Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
- Ticker: Exchange
- EXOZ: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2836
- SIC Description
- Biological Products, (No Diagnostic Substances)
- Ticker
- EXOZ
SEC filing data through
Insider Sentiment
- Last purchase
- 2026-08-26
- Last sale
- 2026-04-09
- Shares purchased (TTM)
- 505
- Shares sold (TTM)
- 750
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 124,554
- Shares outstanding
- 8,660,246
- Ownership
- 1.44%
Earnings Market Reaction
- Filing date
- 2026-08-13
- Price on filing date
- —
- 1-month reaction
- 14.17%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 6 | 1 | 3 | 5 | 7 | 9 | 10 | 0 | ||||||
| Grants Receivable Current | 0 | 0 | 1 | 0 | 0 | 1 | 1 | 1 | ||||||
| Other Receivables Net Current | 0 | - | - | - | - | - | - | - | ||||||
| Prepaid Expense And Other Assets Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | ||||||
| Assets Current | 6 | 2 | 4 | 6 | 8 | 9 | 11 | 1 | ||||||
| Property Plant And Equipment Net | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Operating Lease Right Of Use Asset | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Finance Lease Right Of Use Asset | 0 | 0 | 0 | 0 | 0 | - | - | - | ||||||
| Income Taxes Receivable Noncurrent | - | - | - | 0 | - | - | - | - | ||||||
| Deferred Income Tax Assets Net | 0 | 0 | 0 | - | - | - | - | - | ||||||
| Assets | 8 | 4 | 6 | 8 | 10 | 12 | 13 | 4 | ||||||
Liabilities And Stockholders Equity | ||||||||||||||
| Accounts Payable Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Other Liabilities Current | - | 0 | 0 | 0 | - | 0 | 0 | - | ||||||
| Operating Lease Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Finance Lease Liability Current | 0 | 0 | 0 | 0 | 0 | - | - | - | ||||||
| Liabilities Current | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 6 | ||||||
| Deferred Income Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Operating Lease Liability Noncurrent | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Finance Lease Liability Noncurrent | 0 | 0 | 0 | 0 | 0 | - | - | - | ||||||
| Liabilities | 4 | 2 | 3 | 2 | 2 | 3 | 3 | 7 | ||||||
Stockholders Equity | ||||||||||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 30 | 25 | 25 | 24 | 23 | 23 | 22 | 7 | ||||||
| Retained Earnings Accumulated Deficit | -26 | -23 | -21 | -18 | -16 | -14 | -12 | -10 | ||||||
| Stockholders Equity | 4 | 2 | 3 | 5 | 7 | 9 | 10 | -4 | ||||||
| Liabilities And Stockholders Equity | 8 | 4 | 6 | 8 | 10 | 12 | 13 | 4 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Shares Authorized | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Issued | 9 | 8 | 8 | 8 | 8 | 8 | 8 | 6 | ||||||
| Shares Outstanding | 9 | 8 | 8 | 8 | 8 | 8 | 8 | 6 | ||||||
Select a line item above to chart it.
Recent filings
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialEXOZYMES INC. (EXOZ) — SEC Financial Statements & Analysis
EXOZYMES INC. (EXOZ) is a biological products, (no diagnostic substances) company, incorporated in NV. EXOZYMES INC. trades on Nasdaq as: EXOZ. EXOZYMES INC. (EXOZ)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-13. Based on that filing, EXOZYMES INC. carries a market cap of $73.01M, a P/E ratio of -7.16x, a P/B ratio of 19.98x, an enterprise value of $67.44M, and an EV/EBITDA multiple of -6.57x. On profitability, it posts a Return on Equity (ROE) of -187.16%, a Return on Assets (ROA) of -115.42%, and a Return on Invested Capital (ROIC) of -3681.05%. Per share, it reports EPS of $-1.18, diluted EPS of $-1.18, free cash flow per share of $-0.82, and a dividend per share of $0.00. Over the trailing year, it posted net income growth of 1.12% year-over-year and EPS growth of -2.18% year-over-year. On the balance sheet, it maintains a current ratio of 3.81x, a quick ratio of 3.63x, working capital of $4.55M, a debt-to-equity ratio of 1.18x, a debt ratio of 0.54, an interest coverage ratio of -50.65x, free cash flow of $-7.14M (TTM), and net debt of $-5.57M. Figures sourced from SEC EDGAR.
- Market Cap
- $73.01M
- P/E TTM
- -7.16x
- EPS TTM
- $-1.18
- P/B TTM
- 19.98x
- ROE TTM
- -187.16%
- ROA TTM
- -115.42%
- Debt To Equity
- 1.18x
- Free Cash Flow TTM
- $-7.14M
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is EXOZYMES INC. in?
EXOZYMES INC. (EXOZ) operates in the Biological Products, (No Diagnostic Substances) industry.
What exchange does EXOZ trade on?
EXOZYMES INC. (EXOZ) trades on the Nasdaq.
Where is EXOZYMES INC. incorporated?
EXOZYMES INC. is incorporated in NV.
When was EXOZYMES INC. (EXOZ)'s most recent SEC filing?
EXOZYMES INC. (EXOZ)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-13.
What is EXOZ's market cap?
EXOZYMES INC. (EXOZ) has a market capitalization of $73.01M as of 2026-06-30.
What is EXOZ's EPS (earnings per share)?
EXOZYMES INC. (EXOZ)'s trailing twelve month EPS is $-1.18 as of 2026-06-30.
What is EXOZ's ROE (return on equity)?
EXOZYMES INC. (EXOZ)'s trailing twelve month Return on Equity (ROE) is -187.16% as of 2026-06-30.
What is EXOZ's ROA (return on assets)?
EXOZYMES INC. (EXOZ)'s trailing twelve month Return on Assets (ROA) is -115.42% as of 2026-06-30.
What is EXOZ's ROIC (return on invested capital)?
EXOZYMES INC. (EXOZ)'s trailing twelve month Return on Invested Capital (ROIC) is -3681.05% as of 2026-03-31.
What is EXOZ's EV/EBITDA?
EXOZYMES INC. (EXOZ)'s trailing twelve month EV/EBITDA is -6.57x as of 2026-06-30.